Theralase® Technologies Inc. is a clinical stage pharmaceutical company focused on the Research & Development of light activated Photo Dynamic Compounds (“PDCs”) and the associated drug formulations intended to safely and effectively destroy various cancers. Founded in 1994, Theralase’s operations are divided into two divisions: medical laser technology division that manufactures and commercializes medical laser systems, and the R&D of Photodynamic Therapy for the anti-cancer technology.
